Predictors of readmissions after head and neck cancer surgery: A national perspective

•16% of head and neck cancer surgery patients are readmitted within 30days.•Each readmission costs nearly $15,000 and 20% occur at non-index hospitals.•Early readmissions are more likely to be associated with surgical complications.•Lower socioeconomic status is associated with increased readmission...

Full description

Saved in:
Bibliographic Details
Published in:Oral oncology 2017-08, Vol.71, p.106-112
Main Authors: Chen, Michelle M., Orosco, Ryan K., Harris, Jeremy P., Porter, Julie B., Rosenthal, Eben L., Hara, Wendy, Divi, Vasu
Format: Article
Language:English
Subjects:
Adolescent
Adult
Aged
Female
Head and neck cancer
Head and Neck Neoplasms - surgery
Health Care Costs
Hospital readmission
Humans
Hypopharyngeal cancer
Laryngeal cancer
Male
Medicare - economics
Middle Aged
Oral cavity cancer
Oropharyngeal cancer
Patient care
Patient discharge
Patient readmission
Patient Readmission - economics
Retrospective Studies
Social Class
United States
Young Adult
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:•16% of head and neck cancer surgery patients are readmitted within 30days.•Each readmission costs nearly $15,000 and 20% occur at non-index hospitals.•Early readmissions are more likely to be associated with surgical complications.•Lower socioeconomic status is associated with increased readmissions.•Hypothyroidism, cirrhosis, and rheumatoid arthritis are associated with readmission. Surgical oncology patients have multiple comorbidities and are at high risk of readmission. Prior studies are limited in their ability to capture readmissions outside of the index hospital that performed the surgery. Our goal is to evaluate risk factors for readmission for head and neck cancer patients on a national scale. A retrospective cohort study of head and neck cancer patients in the Nationwide Readmissions Database (2013). Our main outcome was 30-day readmission. Statistical analysis included 2-sided t tests, χ2, and multivariate logistic regression analysis. Within 30days, 16.1% of 11,832 patients were readmitted and 20% of readmissions were at non-index hospitals, costing $31million. Hypopharyngeal cancer patients had the highest readmission rate (29.6%), followed by laryngeal (21.8%), oropharyngeal (18.2%), and oral cavity (11.6%) cancers (P
ISSN:1368-8375
1879-0593
DOI:10.1016/j.oraloncology.2017.06.010